Aclaris Therapeutics Stock Price History
| ACRS Stock | USD 1.57 0.02 1.29% |
Below is the normalized historical share price chart for Aclaris Therapeutics extending back to October 07, 2015. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Aclaris Therapeutics stands at 1.57, as last reported on the 21st of March, with the highest price reaching 1.57 and the lowest price hitting 1.55 during the day.
If you're considering investing in Aclaris Stock, it is important to understand the factors that can impact its price. Aclaris Therapeutics secures Sharpe Ratio (or Efficiency) of -0.3, which signifies that the company had a -0.3 % return per unit of risk over the last 3 months. Aclaris Therapeutics exposes twenty-four different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm Aclaris Therapeutics' Standard Deviation of 3.73, risk adjusted performance of (0.27), and Mean Deviation of 2.77 to double-check the risk estimate we provide.
At this time, Aclaris Therapeutics' Common Stock Total Equity is comparatively stable compared to the past year. Common Stock is likely to gain to 1,208 in 2025, whereas Common Stock Shares Outstanding is likely to drop slightly above 42.4 M in 2025. . Price To Sales Ratio is likely to drop to 9.73 in 2025. Price Earnings Ratio is likely to drop to -1.52 in 2025. Aclaris Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date | 200 Day MA 1.8756 | 50 Day MA 2.2 | Beta 0.496 |
Aclaris |
Sharpe Ratio = -0.303
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | ACRS |
Estimated Market Risk
| 3.22 actual daily | 28 72% of assets are more volatile |
Expected Return
| -0.98 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.3 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Aclaris Therapeutics is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Aclaris Therapeutics by adding Aclaris Therapeutics to a well-diversified portfolio.
Price Book 1.0776 | Enterprise Value Ebitda 0.2785 | Price Sales 8.9546 | Shares Float 66.1 M | Wall Street Target Price 9.8333 |
Aclaris Therapeutics Stock Price History Chart
There are several ways to analyze Aclaris Stock price data. The simplest method is using a basic Aclaris candlestick price chart, which shows Aclaris Therapeutics price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
| Highest Price | December 26, 2024 | 2.92 |
| Lowest Price | March 19, 2025 | 1.55 |
Aclaris Therapeutics March 21, 2025 Stock Price Synopsis
Various analyses of Aclaris Therapeutics' daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell Aclaris Stock. It can be used to describe the percentage change in the price of Aclaris Therapeutics from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of Aclaris Stock.| Aclaris Therapeutics Price Daily Balance Of Power | 1.00 | |
| Aclaris Therapeutics Price Rate Of Daily Change | 1.01 | |
| Aclaris Therapeutics Price Action Indicator | 0.02 |
Aclaris Therapeutics March 21, 2025 Stock Price Analysis
Aclaris Stock Price History Data
The price series of Aclaris Therapeutics for the period between Sat, Dec 21, 2024 and Fri, Mar 21, 2025 has a statistical range of 1.99 with a coefficient of variation of 19.02. The prices are distributed with arithmetic mean of 2.37. The median price for the last 90 days is 2.46.| Open | High | Low | Close | Volume | ||
03/21/2025 | 1.55 | 1.57 | 1.55 | 1.57 | ||
| 03/20/2025 | 1.55 | 1.64 | 1.53 | 1.57 | 746,918 | |
| 03/19/2025 | 1.59 | 1.61 | 1.54 | 1.55 | 1,220,748 | |
| 03/18/2025 | 1.59 | 1.62 | 1.55 | 1.58 | 2,128,438 | |
| 03/17/2025 | 1.56 | 1.61 | 1.50 | 1.58 | 1,607,056 | |
| 03/14/2025 | 1.56 | 1.59 | 1.54 | 1.56 | 945,560 | |
| 03/13/2025 | 1.57 | 1.67 | 1.54 | 1.56 | 1,095,897 | |
| 03/12/2025 | 1.67 | 1.69 | 1.58 | 1.59 | 3,631,508 | |
| 03/11/2025 | 1.63 | 1.70 | 1.61 | 1.65 | 886,508 | |
| 03/10/2025 | 1.83 | 1.83 | 1.63 | 1.66 | 912,724 | |
| 03/07/2025 | 1.88 | 2.03 | 1.82 | 1.83 | 1,197,761 | |
| 03/06/2025 | 1.77 | 1.87 | 1.75 | 1.82 | 680,253 | |
| 03/05/2025 | 1.92 | 1.96 | 1.84 | 1.85 | 439,994 | |
| 03/04/2025 | 1.88 | 1.97 | 1.86 | 1.93 | 622,281 | |
| 03/03/2025 | 2.01 | 2.09 | 1.94 | 1.96 | 547,597 | |
| 02/28/2025 | 1.90 | 2.02 | 1.77 | 1.99 | 1,102,698 | |
| 02/27/2025 | 2.17 | 2.17 | 1.94 | 1.95 | 640,229 | |
| 02/26/2025 | 2.07 | 2.13 | 2.05 | 2.10 | 636,783 | |
| 02/25/2025 | 2.07 | 2.09 | 2.00 | 2.06 | 510,630 | |
| 02/24/2025 | 2.23 | 2.25 | 2.05 | 2.07 | 495,954 | |
| 02/21/2025 | 2.29 | 2.34 | 2.22 | 2.24 | 369,992 | |
| 02/20/2025 | 2.33 | 2.34 | 2.24 | 2.31 | 354,822 | |
| 02/19/2025 | 2.30 | 2.42 | 2.26 | 2.31 | 621,609 | |
| 02/18/2025 | 2.35 | 2.38 | 2.24 | 2.30 | 423,304 | |
| 02/14/2025 | 2.18 | 2.35 | 2.17 | 2.33 | 473,669 | |
| 02/13/2025 | 2.19 | 2.24 | 2.14 | 2.20 | 388,490 | |
| 02/12/2025 | 2.13 | 2.22 | 2.11 | 2.17 | 726,136 | |
| 02/11/2025 | 2.37 | 2.37 | 2.19 | 2.20 | 412,708 | |
| 02/10/2025 | 2.54 | 2.55 | 2.38 | 2.39 | 604,356 | |
| 02/07/2025 | 2.46 | 2.54 | 2.40 | 2.49 | 715,171 | |
| 02/06/2025 | 2.60 | 2.60 | 2.39 | 2.43 | 792,531 | |
| 02/05/2025 | 2.49 | 2.60 | 2.46 | 2.57 | 643,642 | |
| 02/04/2025 | 2.38 | 2.56 | 2.33 | 2.51 | 703,511 | |
| 02/03/2025 | 2.39 | 2.51 | 2.37 | 2.40 | 544,759 | |
| 01/31/2025 | 2.50 | 2.60 | 2.36 | 2.48 | 2,883,554 | |
| 01/30/2025 | 2.37 | 2.42 | 2.34 | 2.39 | 304,627 | |
| 01/29/2025 | 2.40 | 2.41 | 2.28 | 2.36 | 497,200 | |
| 01/28/2025 | 2.45 | 2.47 | 2.33 | 2.39 | 636,551 | |
| 01/27/2025 | 2.47 | 2.54 | 2.39 | 2.45 | 510,235 | |
| 01/24/2025 | 2.58 | 2.58 | 2.48 | 2.51 | 523,615 | |
| 01/23/2025 | 2.56 | 2.58 | 2.49 | 2.55 | 694,865 | |
| 01/22/2025 | 2.61 | 2.61 | 2.51 | 2.60 | 804,029 | |
| 01/21/2025 | 2.61 | 2.64 | 2.48 | 2.60 | 838,299 | |
| 01/17/2025 | 2.54 | 2.59 | 2.46 | 2.57 | 506,937 | |
| 01/16/2025 | 2.49 | 2.53 | 2.44 | 2.51 | 378,510 | |
| 01/15/2025 | 2.56 | 2.57 | 2.42 | 2.51 | 518,123 | |
| 01/14/2025 | 2.50 | 2.50 | 2.31 | 2.50 | 2,692,907 | |
| 01/13/2025 | 2.46 | 2.49 | 2.38 | 2.48 | 2,164,631 | |
| 01/10/2025 | 2.43 | 2.47 | 2.32 | 2.47 | 1,661,360 | |
| 01/08/2025 | 2.46 | 2.51 | 2.40 | 2.46 | 635,056 | |
| 01/07/2025 | 2.51 | 2.60 | 2.43 | 2.50 | 531,568 | |
| 01/06/2025 | 2.63 | 2.65 | 2.45 | 2.53 | 843,980 | |
| 01/03/2025 | 2.49 | 2.80 | 2.49 | 2.60 | 1,045,722 | |
| 01/02/2025 | 2.50 | 2.62 | 2.48 | 2.48 | 501,601 | |
| 12/31/2024 | 2.63 | 2.65 | 2.35 | 2.48 | 909,677 | |
| 12/30/2024 | 2.68 | 2.74 | 2.48 | 2.48 | 827,210 | |
| 12/27/2024 | 2.96 | 2.97 | 2.71 | 2.73 | 552,285 | |
| 12/26/2024 | 2.91 | 3.02 | 2.80 | 2.92 | 761,195 | |
| 12/24/2024 | 2.96 | 2.97 | 2.84 | 2.90 | 499,772 | |
| 12/23/2024 | 2.99 | 3.12 | 2.84 | 2.89 | 1,803,555 | |
| 12/20/2024 | 2.74 | 2.90 | 2.71 | 2.72 | 1,158,345 |
About Aclaris Therapeutics Stock history
Aclaris Therapeutics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Aclaris is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Aclaris Therapeutics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Aclaris Therapeutics stock prices may prove useful in developing a viable investing in Aclaris Therapeutics
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 77.3 M | 42.4 M | |
| Net Loss | -78.2 M | -82.1 M |
Aclaris Therapeutics Quarterly Net Working Capital |
|
Aclaris Therapeutics Stock Technical Analysis
Aclaris Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Did you try this?
Run USA ETFs Now
USA ETFsFind actively traded Exchange Traded Funds (ETF) in USA |
| All Next | Launch Module |
Aclaris Therapeutics Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Aclaris Therapeutics' price direction in advance. Along with the technical and fundamental analysis of Aclaris Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Aclaris to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | (0.27) | |||
| Jensen Alpha | (1.15) | |||
| Total Risk Alpha | (0.87) | |||
| Treynor Ratio | (2.64) |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Additional Tools for Aclaris Stock Analysis
When running Aclaris Therapeutics' price analysis, check to measure Aclaris Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Aclaris Therapeutics is operating at the current time. Most of Aclaris Therapeutics' value examination focuses on studying past and present price action to predict the probability of Aclaris Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Aclaris Therapeutics' price. Additionally, you may evaluate how the addition of Aclaris Therapeutics to your portfolios can decrease your overall portfolio volatility.